Acute hepatic failure – Diagnostics – Overview of Information and Clinical Research

Acute hepatic failure is a medical emergency where the liver suddenly loses its ability to function properly within days to weeks, often striking people who previously had no liver problems at all. When this happens, the body quickly accumulates toxins that should have been filtered out, leading to serious complications affecting the brain, blood clotting, and other vital systems. Swift recognition and proper diagnostic evaluation can make the difference between life and death.

Introduction: Who Needs Diagnostic Testing

If you suddenly develop yellowing of your skin and the whites of your eyes, along with confusion or unusual changes in your mental state, you need immediate medical attention. Acute hepatic failure can develop rapidly in someone who never had liver disease before, making early diagnosis absolutely critical. This condition is uncommon but extremely dangerous, with the liver shutting down over just days or weeks rather than the months or years typical of chronic liver disease.^[1]

Anyone experiencing symptoms like severe nausea and vomiting, pain in the upper right part of the belly, extreme tiredness accompanied by yellowing skin, or mental confusion should seek emergency care without delay. Because acute hepatic failure progresses so quickly, waiting to see if symptoms improve on their own can be fatal. The condition requires hospitalization, often in an intensive care unit, where doctors can perform the necessary tests and provide life-saving treatment.^[2]

People who have taken large amounts of acetaminophen (found in many pain relievers like Tylenol), those exposed to hepatitis viruses, or anyone who has ingested poisonous substances should be evaluated immediately if they develop any signs of liver problems. Even if you feel only mildly unwell at first, acute hepatic failure can worsen dramatically within hours. Family members or close contacts who notice a person becoming increasingly confused, sleepy, or disoriented should not hesitate to call for emergency medical help.^[4]

⚠️ Important

Acute hepatic failure is a true medical emergency that can be life-threatening within days. If you or someone you know suddenly develops jaundice (yellowing of skin and eyes), confusion, or severe belly pain, do not wait to see a doctor. Go to the emergency room immediately or call emergency services. Every hour counts when the liver is failing rapidly.

Classic Diagnostic Methods

When doctors suspect acute hepatic failure, they must act quickly to confirm the diagnosis and identify what caused it. The most important first step involves blood tests that reveal how well the liver is working. These tests look at several key markers that tell doctors whether the liver has stopped performing its essential jobs.^[9]

A prothrombin time test measures how long it takes for blood to clot. This is one of the most critical tests because a healthy liver produces the proteins needed for blood to clot properly. When acute hepatic failure occurs, blood takes much longer to clot than it should. Doctors use a measurement called the international normalized ratio, or INR for short. An INR greater than 1.5 is one of the defining features of acute hepatic failure and signals that the liver has lost significant function.^[2]

Blood tests also measure liver enzymes called aspartate aminotransferase (AST) and alanine aminotransferase (ALT). These enzymes are normally found inside liver cells, but when liver cells are damaged or dying, the enzymes leak into the bloodstream. Very high levels, often exceeding 3,000 units per liter, suggest severe liver damage. The pattern of enzyme elevation can provide clues about the cause. For example, if AST is much higher than ALT, this may point to liver damage from reduced blood flow or acetaminophen poisoning.^[4]

Doctors also check bilirubin levels in the blood. Bilirubin is a yellow substance that builds up when the liver cannot process it properly, causing the characteristic yellowing of skin and eyes called jaundice. High bilirubin levels confirm that liver function is severely impaired. Additionally, blood tests measure ammonia levels, which are particularly important because ammonia is toxic to the brain. When the liver fails, ammonia accumulates in the blood and can cause brain swelling and confusion. Higher ammonia levels are associated with a greater risk of serious brain complications.^[4]

A complete blood count checks for low platelet levels, which can occur when the liver is failing. Doctors also test blood glucose levels because the liver normally helps maintain blood sugar, and acute hepatic failure can cause dangerously low glucose. Blood lactate levels and kidney function tests are also performed, as these organs are often affected when the liver fails.^[6]

To identify the cause of acute hepatic failure, doctors order specific tests based on what they suspect. Blood tests can detect viral hepatitis infections, particularly hepatitis A, B, and E. If acetaminophen overdose is suspected, blood levels of this medication are measured. Tests for autoimmune antibodies may be done if autoimmune hepatitis is a possibility. In younger patients with neurological symptoms, doctors may check for Wilson’s disease, a rare genetic condition that causes copper to accumulate in the liver. Low levels of alkaline phosphatase combined with high liver enzymes can be a clue pointing toward Wilson’s disease.^[4]

After blood tests, imaging studies help visualize the liver and surrounding structures. An ultrasound examination is typically the first imaging test performed. This painless test uses sound waves to create pictures of the liver and can show whether the liver appears damaged, whether blood vessels are blocked, or whether there are tumors. Ultrasound with Doppler can check blood flow through the liver’s blood vessels, helping to rule out conditions like Budd-Chiari syndrome, where blood clots block the veins leaving the liver.^[9]

If ultrasound results are unclear or if doctors need more detailed images, they may recommend a computed tomography (CT) scan or magnetic resonance imaging (MRI) of the abdomen. These advanced imaging tests provide cross-sectional pictures of the liver and can detect problems that ultrasound might miss, such as tumors, blood vessel abnormalities, or signs of certain infections.^[9]

In some cases, doctors need to examine a small piece of liver tissue under a microscope to determine the exact cause of liver failure. This procedure, called a liver biopsy, involves removing a tiny sample of liver tissue. However, because people with acute hepatic failure have blood clotting problems, standard liver biopsy can be risky and cause dangerous bleeding. To reduce this risk, doctors may perform a special type of biopsy called a transjugular liver biopsy. During this procedure, a thin tube is inserted through a vein in the neck, threaded down through the heart, and into a vein in the liver. A needle is then passed through the tube to collect the tissue sample. This approach is safer because it avoids making an incision that could bleed uncontrollably.^[9]

Doctors also carefully review the patient’s medical history, asking detailed questions about recent medication use, including over-the-counter drugs and herbal supplements. They inquire about potential exposure to hepatitis viruses, alcohol use, whether the patient has eaten wild mushrooms, and any history of autoimmune diseases or previous liver problems. If the patient is too confused to provide information, family members or friends are asked to help fill in these important details.^[4]

Repeated monitoring of blood tests every few hours helps doctors track whether the patient is improving with treatment or getting worse. This ongoing assessment is crucial for deciding whether the patient might recover with intensive supportive care alone or whether a liver transplant will be necessary.^[4]

Diagnostics for Clinical Trial Qualification

When patients with acute hepatic failure are being considered for participation in clinical trials, additional standardized diagnostic criteria must be met beyond the routine tests used for diagnosis and treatment. Clinical trials often have very specific requirements to ensure that all participants have a similar severity of illness, making it possible to properly evaluate whether experimental treatments are working.^[2]

The fundamental diagnostic criteria for qualifying patients typically include the presence of hepatic encephalopathy along with an INR of 1.5 or higher, with symptoms developing within 26 weeks in someone without pre-existing cirrhosis or chronic liver disease. However, clinical trials may have stricter definitions. For example, some trials may only include patients whose symptoms developed within a shorter timeframe, or they may require specific stages of encephalopathy to ensure participants have comparable disease severity.^[2]

Clinical trials often use classification systems to categorize how rapidly the condition developed. The O’Grady classification system divides acute hepatic failure into three categories based on how quickly encephalopathy developed after jaundice appeared. Hyperacute failure occurs when encephalopathy develops in less than 7 days, acute failure when it develops between 1 and 4 weeks, and subacute failure when it develops after more than 4 weeks. These categories are important because they help predict outcomes and may determine which patients are suitable for specific trials.^[2]

For trial enrollment, comprehensive laboratory testing is required not just to confirm the diagnosis but also to establish baseline measurements that can be tracked throughout the study. This typically includes repeated measurements of liver enzyme levels (AST and ALT), bilirubin, INR, and other blood clotting factors. Kidney function tests are essential because many clinical trials exclude patients whose kidneys have already failed. Blood tests measuring electrolytes, glucose, ammonia, lactate, and pH levels are often required to document the full extent of organ dysfunction.^[4]

Some clinical trials may require specialized tests to measure markers of liver regeneration, such as alpha-fetoprotein (AFP) or phosphorus levels. Elevated AFP or low phosphorus can suggest that the liver is attempting to regenerate new cells, which might indicate a better chance of recovery without transplantation.^[4]

Imaging studies serve as both diagnostic tools and baseline assessments in clinical trials. Ultrasound with Doppler to assess blood flow patterns, CT scans, or MRI studies may be required before enrollment to rule out conditions that would exclude patients from participation, such as tumors or chronic liver disease that was previously unrecognized.^[2]

Advanced monitoring techniques may be used in certain trials. For example, trials studying treatments for brain swelling might require intracranial pressure monitoring, where a device is placed to directly measure pressure inside the skull. Some studies use electroencephalography (EEG), which measures electrical activity in the brain, to assess the degree of brain dysfunction. Another specialized test measures the diameter of the optic nerve sheath using ultrasound, which can provide information about whether pressure is building up inside the skull.^[2]

Documentation of the cause of acute hepatic failure is typically required for trial enrollment. This means patients must undergo all the necessary tests to identify whether the failure was caused by acetaminophen toxicity, viral hepatitis, autoimmune disease, drug reactions, or other causes. Some trials only accept patients with specific causes, while others exclude certain causes. For instance, a trial testing a new therapy for drug-induced liver failure might exclude patients whose failure was caused by acetaminophen since specific treatments already exist for that condition.^[4]

Blood cultures and infection screening are often mandatory before trial enrollment because infections can complicate the picture and affect how patients respond to experimental treatments. Many trials require that patients be free of active, uncontrolled infections at the time of enrollment.^[6]

The timing of diagnostic testing is also important in clinical trial settings. Because acute hepatic failure progresses so rapidly, trials often specify that certain tests must be performed within a particular timeframe, such as within 24 hours of presentation or before certain treatments are started. This ensures that baseline measurements truly reflect the patient’s condition at a consistent point in their illness.^[4]

⚠️ Important

Clinical trials for acute hepatic failure have very specific enrollment criteria that may be more restrictive than the general definition of the disease. Not all patients with acute hepatic failure will qualify for every trial. Your medical team will help determine which trials, if any, might be appropriate for your specific situation based on comprehensive diagnostic testing results.

Prognosis and Survival Rate

Prognosis

The outlook for patients with acute hepatic failure depends heavily on several factors, particularly what caused the liver damage and how quickly treatment begins. Patients whose liver failure developed very rapidly, within the first week after symptoms began (hyperacute failure), actually have a better chance of recovery without needing a liver transplant compared to those whose failure developed more slowly over several weeks. This may seem surprising, but it appears that when the liver fails suddenly, it sometimes has a better capacity to regenerate once the damaging factor is removed.^[2]

The cause of liver failure significantly affects the chances of survival. In the United States, where acetaminophen overdose is the most common cause, patients who receive specific treatment with an antidote called N-acetylcysteine have improved outcomes if treatment begins early. For other causes like viral hepatitis or autoimmune disease, the prognosis varies depending on whether specific treatments are available and how quickly they can be started.^[16]

The development of certain complications worsens the prognosis considerably. Brain swelling, called cerebral edema, occurs in approximately 80 percent of patients who progress to the deepest stage of confusion and coma (grade IV hepatic encephalopathy). This complication can lead to brain herniation and death. The level of ammonia in the blood correlates with the risk of developing cerebral edema, with higher levels indicating greater danger.^[4]

Kidney failure, which often accompanies liver failure, also worsens the outlook. When both organs fail simultaneously, the body’s ability to clear toxins becomes even more compromised, and the risk of death increases substantially. Infections are another serious complication that can develop during acute hepatic failure, and patients who develop severe infections have poorer outcomes.^[8]

The interval between the first appearance of jaundice and the development of confusion or encephalopathy is considered a critical indicator of prognosis. When this interval is very short, it paradoxically suggests a better chance of recovery. When encephalopathy develops weeks after jaundice appears, the prognosis without transplantation is generally poorer.^[2]

Survival rate

Overall survival rates for acute hepatic failure have improved dramatically over the past few decades due to better intensive care and the availability of liver transplantation. Historically, only about 20 percent of patients survived this condition. However, with modern medical care, survival rates have increased to greater than 60 percent in some centers. When all patients are considered together, regardless of whether they receive a transplant, approximately 50 percent survive.^[4]

For patients who undergo liver transplantation for acute hepatic failure, survival rates are quite good. One-year survival after transplant exceeds 80 percent at experienced centers. This means that if a patient receives a transplant in time, before irreversible complications develop, the chances of surviving the first year are excellent.^[2]

Survival without transplantation varies considerably depending on the cause and severity of the liver failure. Patients with hyperacute liver failure from certain causes have higher rates of spontaneous recovery without needing a transplant. However, for many other causes, particularly when the failure develops more slowly, the survival rate without transplantation remains low. This is why timely evaluation for potential liver transplantation is critical for all patients with acute hepatic failure.^[2]

The good news for those who do survive, whether with or without transplantation, is that acute hepatic failure is a potentially reversible condition. Patients who recover completely typically do so without long-term liver damage or ongoing liver disease, assuming the underlying cause has been addressed. This is distinctly different from chronic liver disease, where permanent scarring often persists even after treatment.^[21]

#1 Clinical Trials Search in Europe